These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30572434)

  • 1. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
    Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
    Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.
    Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
    Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
    Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
    Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Adachi N; Ochi M
    Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
    Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
    Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
    Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
    J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases.
    Kobayashi Y; Ozaki T; Takeda Y; Kawai A; Inoue H
    Acta Orthop Scand; 1998 Dec; 69(6):611-6. PubMed ID: 9930108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK; Lou C; Shi GH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wu F; Huang Y; Huang X; Fang S; Huang X; Huang X; Zhang Z; Shao Z
    Front Oncol; 2020; 10():762. PubMed ID: 32528883
    [No Abstract]   [Full Text] [Related]  

  • 10. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
    Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
    Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
    Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
    Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
    Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the alteration uptake ratio of
    Huang Z; Lou C
    Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
    Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
    Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis.
    Hongtao L; Hui Z; Bingshun W; Xiaojin W; Zhiyu W; Shuier Z; Aina H; Yuanjue S; Daliu M; Zan S; Yang Y
    Surg Oncol; 2012 Dec; 21(4):e165-70. PubMed ID: 22884956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
    Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
    Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.